How Roche’s new deal with LumiraDx will transform Point of Care testing forever
Roche Holding AG has finalised its acquisition of LumiraDx’s innovative Point of Care technology, a strategic move aimed at enhancing its diagnostic portfolio and expanding global access to essential healthcare. The completion of this acquisition, following all necessary antitrust and regulatory approvals, marks a significant milestone for Roche as it integrates LumiraDx’s multi-assay point of […]
